Larvol Delta - Cognition-Therapeutics-Highlights-Phase-2-SHIMMER-Study-of-CT1812-in-Dementia-with-Lewy-Bodies-in-Presentation-at-CTAD

Elayta (CT1812) - Cognition Therap

https://www.globenewswire.com/news-release/2022/11/28/2563118/0/en/Cognition-Therapeutics-Highlights-Phase-2-SHIMMER-Study-of-CT1812-in-Dementia-with-Lewy-Bodies-in-Presentation-at-CTAD.html

Nov 28, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next